Genomics in the era of COVID-19: ethical implications for clinical practice and public health

Genome Med. 2020 Nov 9;12(1):95. doi: 10.1186/s13073-020-00792-9.

Abstract

Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications-both potential benefits and harms-of genomics for clinical practice and public health in the era of COVID-19.

Keywords: COVID-19; Ethics; Host genomics.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Clinical Decision-Making / methods
  • Coronavirus Infections / pathology*
  • Coronavirus Infections / therapy
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing / ethics*
  • Genomics / ethics*
  • Genomics / methods
  • Humans
  • Pandemics
  • Pneumonia, Viral / pathology*
  • Pneumonia, Viral / therapy
  • Public Health / ethics*
  • Public Health / methods
  • SARS-CoV-2